Re: Discussing breast cancer screening with patients

Issue: BCMJ, vol. 56, No. 2, March 2014, Page 76 Letters
By: Paula B. Gordon, OBC, MD, FRCPC, FSBI

Dr Coldman and colleagues are to be commended on their efforts to discuss the complex issues involved in helping women decide whether to participate in screening mammography (Information for physicians discussing breast cancer screening with patients, BCMJ 2013;55:420-428). Some points deserve clarification.

In the Health Notes intended for women they state, “Two possible benefits from breast screening include:
•    A reduced risk of dying from breast cancer.
•    The need for less intensive treatment for breast cancer.”

They should have been more specific.

1. Early detection allows breast conservation. Women need to know that the likelihood of mastectomy increases with an increasing time interval between mammograms.

2. Early detection allows avoidance of axillary dissection, which has the adverse complication of lymphedema.

3. I was surprised to see them understate the potential mortality reduction. They state, “If you choose not to screen, you run a slightly higher risk of dying because of having a breast cancer that wasn’t found and treated early enough.” Randomized trials underestimate mortality reduction because they include all women invited, even if they do not attend (noncompliance). But Dr Coldman himself has previously published that there was a 40% mortality reduction among women who chose to be screened in BC.[1] That is not a slight decrease.

4. Overdiagnosis is not important unless it leads to overtreatment. Until our oncologic colleagues (medical and surgical) are able to determine optimal treatment for cancers of varying threats to life, it behooves us to keep screening. If we discourage screening to prevent overtreatment, we lose the opportunity to discover lethal cancers at a stage when they can be optimally treated.

5. The authors admit the randomized trial data were obtained using film mammography, which is being phased out and replaced by digital. But they made no mention of tomosynthesis (3D mammography), which is arguably the future of mammography screening. Tomosynthesis addresses both sides of the risk-benefit equation. There is ample and growing scientific data showing it increases cancer detection by 30% while at the same time reducing false positives by 40%.[2,3]
—Paula Gordon, OBC, MD, FRCPC
Medical Director, Sadie Diamond Breast Program

References

1.    Coldman A, Phillips N, Warren L, et al. Breast cancer mortality after screening mammography in British Columbia women. Int J Cancer 2007;120:1076-1080.
2.    Rose SL, Tidwell AL, Bujnoch LJ, et al. AJR Implementation of breast tomosynthesis in a routine screening practice: An observational study. AJR Am J Roentgenol 2013;200:1401-1408.
3.    Haas BM, Kalra V, Geisel J, et al. Comparison of tomosynthesis plus digital mammography and digital mammography alone for breast cancer screening. Radiology 2013;269:694-700.

hidden

Information for physicians discussing breast cancer screening with patients

Paula B. Gordon, OBC, MD, FRCPC, FSBI. Re: Discussing breast cancer screening with patients. BCMJ, Vol. 56, No. 2, March, 2014, Page(s) 76 - Letters.


Above is the information needed to cite this article in your paper or presentation. The International Committee of Medical Journal Editors (ICMJE) recommends the following citation style, which is the now nearly universally accepted citation style for scientific papers:
Halpern SD, Ubel PA, Caplan AL, Marion DW, Palmer AM, Schiding JK, et al. Solid-organ transplantation in HIV-infected patients. N Engl J Med. 2002;347:284-7.

About the ICMJE and citation styles

The ICMJE is small group of editors of general medical journals who first met informally in Vancouver, British Columbia, in 1978 to establish guidelines for the format of manuscripts submitted to their journals. The group became known as the Vancouver Group. Its requirements for manuscripts, including formats for bibliographic references developed by the U.S. National Library of Medicine (NLM), were first published in 1979. The Vancouver Group expanded and evolved into the International Committee of Medical Journal Editors (ICMJE), which meets annually. The ICMJE created the Recommendations for the Conduct, Reporting, Editing, and Publication of Scholarly Work in Medical Journals to help authors and editors create and distribute accurate, clear, easily accessible reports of biomedical studies.

An alternate version of ICMJE style is to additionally list the month an issue number, but since most journals use continuous pagination, the shorter form provides sufficient information to locate the reference. The NLM now lists all authors.

BCMJ standard citation style is a slight modification of the ICMJE/NLM style, as follows:

  • Only the first three authors are listed, followed by "et al."
  • There is no period after the journal name.
  • Page numbers are not abbreviated.


For more information on the ICMJE Recommendations for the Conduct, Reporting, Editing, and Publication of Scholarly Work in Medical Journals, visit www.icmje.org

BCMJ Guidelines for Authors

Leave a Reply